Regulation of Mac-2BP secretion is mediated by its N-glycan binding to ERGIC-53

Glycobiology

Volumn 23, Issue 7, 2013, Pages 904-916

  Chen, Yang ^a   Hojo, Sanae ^a   Matsumoto, Naoki ^a   Yamamoto, Kazuo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

cargo receptor; ERGIC 53; Mac 2BP; secretion

Indexed keywords

ALPHA 1 ANTITRYPSIN; APOLIPOPROTEIN A1; BINDING PROTEIN; CATHEPSIN X; DIPEPTIDYL PEPTIDASE I; ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT PROTEIN 53; GREEN FLUORESCENT PROTEIN; MAC 2 BINDING PROTEIN; MANNOSE; UNCLASSIFIED DRUG;

ARTICLE; CELL ISOLATION; DNA LIBRARY; ENDOPLASMIC RETICULUM; GENE DELETION; GENETIC SCREENING; GLYCOSYLATION; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSPORT VESICLE;

CARGO RECEPTOR; ERGIC-53; MAC-2BP; SECRETION;

ANTIGENS, NEOPLASM; GLUCANS; HEK293 CELLS; HELA CELLS; HEP G2 CELLS; HUMANS; MANNOSE-BINDING LECTINS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MUTATION; PROTEIN BINDING; PROTEIN TRANSPORT; SECRETORY PATHWAY; VESICULAR TRANSPORT PROTEINS;

EID: 84882768894     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwt027     Document Type: Article

References (42)

1. Appenzeller-Herzog C, Nyfeler B, Burkhard P, Santamaria I, Lopez-Otin C, Hauri HP. 2005. Carbohydrate- and conformation-dependent cargo capture for ER-exit. Mol Biol Cell. 16:1258-1267.
2. Appenzeller-Herzog C, Roche AC, Nufer O, Hauri HP. 2004. pH-induced conversion of the transport lectin ERGIC-53 triggers glycoprotein release. J Biol Chem. 279:12943-12950.
3. Arar C, Carpentier V, Le Caer JP, Monsigny M, Legrand A, Roche AC. 1995. ERGIC-53, a membrane protein of the endoplasmic reticulum-Golgi intermediate compartment, is identical to MR60, an intracellular mannosespecific lectin of myelomonocytic cells. J Biol Chem. 270:3551-3553.
4. Chen Y, Hu D, Yabe R, Tateno H, Qin SY, Matsumoto N, Hirabayashi J, Yamamoto K. 2011. Role of malectin in Glc2Man9GlcNAc2-dependent quality control of {alpha}1-antitrypsin. Mol Biol Cell. 22:3559-3570.
5. Cunningham MA, Pipe SW, Zhang B, Hauri HP, Ginsburg D, Kaufman RJ. 2003. LMAN1 is a molecular chaperone for the secretion of coagulation factor VIII. J Thromb Haemost. 1:2360-2367.
6. Denecke B, Graber S, Schafer C, Heiss A, Woltje M, Jahnen-Dechent W. 2003. Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A. Biochem J. 376:135-145.
7. Elbein AD, Tropea JE, Mitchell M, Kaushal GP. 1990. Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I. J Biol Chem. 265:15599-15605.
8. Grassadonia A, Tinari N, Iurisci I, Piccolo E, Cumashi A, Innominato P, D'Egidio M, Natoli C, Piantelli M, Iacobelli S. 2004. 90K (Mac-2BP) and galectins in tumor progression and metastasis. Glycoconj J. 19:551-556.
9. Hauri HP, Kappeler F, Andersson H, Appenzeller C. 2000. ERGIC-53 and traffic in the secretory pathway. J Cell Sci. 113: 587-596.
10. Inohara H, Akahani S, Koths K, Raz A. 1996. Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion. Cancer Res. 56:4530-4534.
11. Itin C, Roche AC, Monsigny M, Hauri HP. 1996. ERGIC-53 is a functional mannose-selective and calcium-dependent human homologue of leguminous lectins. Mol Biol Cell. 7:483-493.
12. Kamiya Y, Kamiya D, Yamamoto K, Nyfeler B, Hauri HP, Kato K. 2008. Molecular basis of sugar recognition by the human L-type lectins ERGIC-53, VIPL, and VIP36. J Biol Chem. 283:1857-1861.
13. Kappeler F, Klopfenstein DR, Foguet M, Paccaud JP, Hauri HP. 1997. The recycling of ERGIC-53 in the early secretory pathway. ERGIC-53 carries a cytosolic endoplasmic reticulum-exit determinant interacting with COPII. J Biol Chem. 272:31801-31808.
14. Kawasaki N, Ichikawa Y, Matsuo I, Totani K, Matsumoto N, Ito Y, Yamamoto K. 2008. The sugar-binding ability of ERGIC-53 is enhanced by its interaction with MCFD2. Blood. 111:1972-1979.
15. Kawasaki N, Matsuo I, Totani K, Nawa D, Suzuki N, Yamaguchi D, Matsumoto N, Ito Y, Yamamoto K. 2007. Detection of weak sugar binding activity of VIP36 using VIP36-streptavidin complex and membrane-based sugar chains. J Biochem. 141:221-229.
16. Koths K, Taylor E, Halenbeck R, Casipit C, Wang A. 1993. Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain. J Biol Chem. 268:14245-14249.
17. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680-685.
18. Magliery TJ, Wilson CG, Pan W, Mishler D, Ghosh I, Hamilton AD, Regan L. 2005. Detecting protein-protein interactions with a green fluorescent protein fragment reassembly trap: Scope and mechanism. J Am Chem Soc. 127:146-157.
19. Michnick SW, Remy I, Campbell-Valois FX, Vallee-Belisle A, Pelletier JN. 2000. Detection of protein-protein interactions by protein fragment complementation strategies. Methods Enzymol. 328:208-230.
20. Moremen KW, Trimble RB, Herscovics A. 1994. Glycosidases of the asparagine-linked oligosaccharide processing pathway. Glycobiology. 4:113-125.
21. Nichols WC, Seligsohn U, Zivelin A, Terry VH, Hertel CE, Wheatley MA, Moussalli MJ, Hauri HP, Ciavarella N, Kaufman RJ, et al. 1998. Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII. Cell. 93:61-70.
22. Nishio M, Kamiya Y, Mizushima T, Wakatsuki S, Sasakawa H, Yamamoto K, Uchiyama S, Noda M, McKay AR, Fukui K, et al. 2010. Structural basis for the cooperative interplay between the two causative gene products of combined factor V and factor VIII deficiency. Proc Natl Acad Sci USA. 107:4034-4039.
23. Nufer O, Kappeler F, Guldbrandsen S, Hauri HP. 2003. ER export of ERGIC-53 is controlled by cooperation of targeting determinants in all three of its domains. J Cell Sci. 116:4429-4440.
24. Nyfeler B, Michnick SW, Hauri HP. 2005. Capturing protein interactions in the secretory pathway of living cells. Proc Natl Acad Sci USA. 102:6350-6355.
25. Nyfeler B, Reiterer V, Wendeler MW, Stefan E, Zhang B, Michnick SW, Hauri HP. 2008. Identification of ERGIC-53 as an intracellular transport receptor of alpha1-antitrypsin. J Cell Biol. 180:705-712.
26. Nyfeler B, Zhang B, Ginsburg D, Kaufman RJ, Hauri HP. 2006. Cargo selectivity of the ERGIC-53/MCFD2 transport receptor complex. Traffic. 7:1473-1481.
27. Piehler J. 2005. New methodologies for measuring protein interactions in vivo and in vitro. Curr Opin Struct Biol. 15:4-14.
28. Pimpaneau V, Midoux P, Monsigny M, Roche AC. 1991. Characterization and isolation of an intracellular D-mannose-specific receptor from human promyelocytic HL60 cells. Carbohydr Res. 213:95-108.
29. Qin SY, Kawasaki N, Hu D, Tozawa H, Matsumoto N, Yamamoto K. 2012. Subcellular localization of ERGIC-53 under endoplasmic reticulum stress condition. Glycobiology. 22:1709-1720.
30. Reiterer V, Nyfeler B, Hauri HP. 2010. Role of the lectin VIP36 in post-ER quality control of human alpha1-antitrypsin. Traffic. 11:1044-1055.
31. Remy I, Michnick SW. 2004. A cDNA library functional screening strategy based on fluorescent protein complementation assays to identify novel components of signaling pathways. Methods. 32:381-388.
32. Schekman R, Orci L. 1996. Coat proteins and vesicle budding. Science. 271:1526-1533.
33. Schweizer A, Fransen JA, Bachi T, Ginsel L, Hauri HP. 1988. Identification, by a monoclonal antibody, of a 53-kD protein associated with a tubulovesicular compartment at the cis-side of the Golgi apparatus. J Cell Biol. 107:1643-1653.
34. Tisdale EJ, Plutner H, Matteson J, Balch WE. 1997. p53/58 binds COPI and is required for selective transport through the early secretory pathway. J Cell Biol. 137:581-593.
35. Ullrich A, Sures I, D'Egidio M, Jallal B, Powell TJ, Herbst R, Dreps A, Azam M, Rubinstein M, Natoli C, et al. 1994. The secreted tumorassociated antigen 90K is a potent immune stimulator. J Biol Chem. 269: 18401-18407.
36. Vollenweider F, Kappeler F, Itin C, Hauri HP. 1998. Mistargeting of the lectin ERGIC-53 to the endoplasmic reticulum of HeLa cells impairs the secretion of a lysosomal enzyme. J Cell Biol. 142:377-389.
37. Yoshioka Y, Gejyo F, Marti T, Rickli EE, Burgi W, Offnere GD, Troxler RF, Schmid K. 1986. The complete amino acid sequence of the A-chain of human plasma α2HS-glycoprotein. J Biol Chem. 261:1665-1676.
38. Ware FE, Vassilakos A, Peterson PA, Jackson MR, Lehrman MA, Williams DB. 1995. The molecular chaperone calnexin binds Glc1Man9GlcNAc2 oligosaccharide as an initial step in recognizing unfolded glycoproteins. J Biol Chem. 270:4697-4704.
39. Zapun A, Darby NJ, Tessier DC, Michalak M, Bergeron JJ, Thomas DY. 1998. Enhanced catalysis of ribonuclease B folding by the interaction of calnexin or calreticulin with ERp57. J Biol Chem. 273:6009-6012.
40. Zhang B, Cunningham MA, Nichols WC, Bernat JA, Seligsohn U, Pipe SW, McVey JH, Schulte-Overberg U, de Bosch NB, Ruiz-Saez A, et al. 2003. Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex. Nat Genet. 34:220-225.
41. Zhang B, Kaufman RJ, Ginsburg D. 2005. LMAN1 and MCFD2 form a cargo receptor complex and interact with coagulation factor VIII in the early secretory pathway. J Biol Chem. 280:25881-25886.
42. Zheng C, Liu HH, Yuan S, Zhou J, Zhang B. 2010. Molecular basis of LMAN1 in coordinating LMAN1-MCFD2 cargo receptor formation and ER-to-Golgi transport of FV/FVIII. Blood. 116:5698-5706.